CONTI ELISA

Pozzi, F., Conti, E., Remoli, G., Dell'Orto, N., Andreoni, S., Da Re, F., et al. (2025). Core blood biomarkers of Alzheimer's disease: A single-center real-world performance study. JPAD, 12(2) [10.1016/j.tjpad.2024.100027]. Dettaglio

Sala, G., Cuffaro, L., Pozzi, F., Andreoni, S., Bazzini, C., Conti, E., et al. (2025). Multi-pathway blood biomarkers to target and monitor multidimensional prevention of cognitive and functional decline (nested in the IN-TeMPO study framed within the world-wide FINGERS network). FRONTIERS IN AGING NEUROSCIENCE, 17 [10.3389/fnagi.2025.1581892]. Dettaglio

Saez-Atienzar, S., Souza, C., Chia, R., Beal, S., Lorenzini, I., Huang, R., et al. (2024). Mechanism-free repurposing of drugs for C9orf72-related ALS/FTD using large-scale genomic data. CELL GENOMICS, 4(11) [10.1016/j.xgen.2024.100679]. Dettaglio

Pozzi, F., Cerina, V., Licciardo, D., Guo, W., Brambilla, A., Cosentino, G., et al. (2023). Clinical applicability of pCASL as a substitute for FDG-PET in the etiological diagnosis of MCI and SCD: CAPE study protocol. Intervento presentato a: Neuromi 2023, Milano, Italia. Dettaglio

Conti, E., Grana, D., Angiulli, F., Karantzoulis, A., Villa, C., Combi, R., et al. (2023). TSPO Modulates Oligomeric Amyloid-β-Induced Monocyte Chemotaxis: Relevance for Neuroinflammation in Alzheimer's Disease. JOURNAL OF ALZHEIMER'S DISEASE, 95(2), 549-559 [10.3233/JAD-230239]. Dettaglio